Targeting Herpetic Keratitis by Gene Therapy

Ocular gene therapy is rapidly becoming a reality. By November 2012, approximately 28 clinical trials were approved to assess novel gene therapy agents. Viral infections such as herpetic keratitis caused by herpes simplex virus 1 (HSV-1) can cause serious complications that may lead to blindness. Re...

Descripción completa

Detalles Bibliográficos
Autores principales: Elbadawy, Hossein Mostafa, Gailledrat, Marine, Desseaux, Carole, Ponzin, Diego, Ferrari, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541562/
https://www.ncbi.nlm.nih.gov/pubmed/23326647
http://dx.doi.org/10.1155/2012/594869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541562/
https://www.ncbi.nlm.nih.gov/pubmed/23326647
http://dx.doi.org/10.1155/2012/594869

Ejemplares similares